Chronic Heart Failure - Cheyne Stokes Respiration - CS2 (3C-study)
NCT ID: NCT00563693
Last Updated: 2015-12-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
40 participants
INTERVENTIONAL
2007-09-30
2011-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Several patients with chronic heart failure also has Cheyne Stokes respiration pattern. Earlier studies have shown that this respiration pattern improves with Adaptive servo ventilator. We wish to investigate wether this leads to improved cardiac function.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
A
The patients use ASV
ASV
Adaptive servo ventilator
without Autoset CS2
without Autoset CS2
B
Patients without ASV
without Autoset CS2
without Autoset CS2
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
ASV
Adaptive servo ventilator
without Autoset CS2
without Autoset CS2
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* NYHA class III-IV
* Optimized therapy with drugs
* Cheyne stokes respiration pattern \> 25% while sleeping
* Age \< 85 years
* clinical stability the last month before inclusion.
Exclusion Criteria
* PCI treatment less then 3 months ago
* Unstable angina pectoris
* Acute coronary syndrome less then 3 months ago
* Stroke less then 6 weeks ago
* Thoracal myopathy
* Advanced COPD
18 Years
85 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
ResMed
INDUSTRY
University of Oslo
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Arild Hetland
MD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Arild Hetland, cardiologist
Role: PRINCIPAL_INVESTIGATOR
University of Oslo
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Sykehuset ostfold Fredrikstad
Fredrikstad, , Norway
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1.2007.980
Identifier Type: -
Identifier Source: org_study_id